Patient-Directed Education to Promote Deprescribing: A Nonrandomized Clinical Trial.

ABSTRACT:

Importance

Patient-directed educational materials are a promising implementation strategy to expand deprescribing reach and adoption, but little is known about the impact across medication groups with potentially different perceived risks.

Objective

To examine the impact of a patient-directed education intervention on clinician deprescribing of potentially low-benefit (proton pump inhibitors) or high-risk medications (high-dose gabapentin, diabetes agents with hypoglycemia risks).

Design, setting, and participants

This pragmatic multisite nonrandomized clinical trial took place at 3 geographically distinct US Veterans Affairs (VA) medical centers from April 2021 to October 2022. The total study sample was composed of the intervention cohort and the historical control

SUBMITTER: Jones KF 

PROVIDER: S-EPMC11420822 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature